Skip to main content
CGON logo

CGON · CG Oncology, Inc. · Analyst Estimates

Track CGON — free
$70.89 +0.37 (+0.52%) At close · Sep 30
Market Cap
$6.24B
Shares
88.64M
Volume · Sep 30 1.33M Avg daily vol (3M) 889.05K

Analyst Estimates

Compare analyst forecasts for CG Oncology, Inc. across metrics and forecast periods.

Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.

Compiled consensus

These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians.

Captured 2026-09-22 21:57 UTC · Publication dates shown per estimate · 16 metric / period groups

FY ending 2026-12-31

Analyst estimates for FY ending 2026-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-3.6
-3.22994
-2.79
—
-3.20456
-2.67141
-3.20456
-2.65514
— — — —
EPS
analysts
Publication date not stated
— — —
12
— — — —
10
0
0
0
Revenue
USD
Publication date not stated
2200000
4469720
18250000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
13
— — — — — — — —

FY ending 2027-12-31

Analyst estimates for FY ending 2027-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-3.63407
-3.02065
-2.15
—
-2.90371
-2.77916
-3.02065
-2.77916
— — — —
EPS
analysts
Publication date not stated
— — —
12
— — — —
7
1
2
0
Revenue
USD
Publication date not stated
0
83515880
183000000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
13
— — — — — — — —

Q ending 2026-09-30

Analyst estimates for Q ending 2026-09-30
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-0.96
-0.80966
-0.66
—
-0.81555
-0.66726
-0.80966
-0.66726
— — — —
EPS
analysts
Publication date not stated
— — —
12
— — — —
10
0
0
0
Revenue
USD
Publication date not stated
0
534480
1180140
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
12
— — — — — — — —

Q ending 2026-12-31

Analyst estimates for Q ending 2026-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-1.03
-0.83815
-0.67
—
-0.84073
-0.61878
-0.83815
-0.61878
— — — —
EPS
analysts
Publication date not stated
— — —
12
— — — —
9
0
0
0
Revenue
USD
Publication date not stated
0
531180
1270000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
12
— — — — — — — —
Key facts CIK 1991792 CUSIP 156944100 13F (30d) 8 filings 8 filers Visit website Investor relations